Close Menu

At the University of Pennsylvania, genome researchers have created a method for analyzing concordant genomic aberrations for determining important regions for tumor progression, according to a paper in PLoS Genetics. Using a method called Multiple Sample Analysis, they used microarrays to create profiles of conserved aberrations in certain cancer types, allowing them to validate targets for cancer therapies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new study catalogues the genome and evolutionary history of the oak family, UPI reports.

Dog DNA testing is a growing market, but there's still a lot of uncertainty about the accuracy of the results, the Boston Globe says.

A University of South Florida researcher is testing bone fragments to determine if they belong to Amelia Earhart.

In Cell this week: antisense Piwi-interacting RNA responses to endogenous retroviruses, proteomic patterns in hepatocellular carcinoma, and more.